398 related articles for article (PubMed ID: 16950189)
1. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
Moe GW; Howlett J; Januzzi JL; Zowall H;
Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients.
Chenevier-Gobeaux C; Delerme S; Allo JC; Arthaud M; Claessens YE; Ekindjian OG; Riou B; Ray P
Clin Biochem; 2008 Sep; 41(13):1049-54. PubMed ID: 18573245
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
[TBL] [Abstract][Full Text] [Related]
9. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
Shenkman HJ; Zareba W; Bisognano JD
Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
13. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea.
Green SM; Martinez-Rumayor A; Gregory SA; Baggish AL; O'Donoghue ML; Green JA; Lewandrowski KB; Januzzi JL
Arch Intern Med; 2008 Apr; 168(7):741-8. PubMed ID: 18413557
[TBL] [Abstract][Full Text] [Related]
14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.
Mueller C; Laule-Kilian K; Schindler C; Klima T; Frana B; Rodriguez D; Scholer A; Christ M; Perruchoud AP
Arch Intern Med; 2006 May; 166(10):1081-7. PubMed ID: 16717170
[TBL] [Abstract][Full Text] [Related]
16. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
17. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
19. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]